The number of novel coronavirus cases in the United States topped 7 million – more than 20% of the world’s total – as Midwest states reported spikes in Covid-19 infections in September, according to a Reuters tally.
If you are not happy with the results below please do another search
50 search results for:
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy does not appear to increase the risk of complications during delivery or negatively impact the health of newborns, according to a new JAMA study.
Bristol Myers Squibb announced that CheckMate -274, a pivotal Phase 3 trial evaluating Opdivo (nivolumab) after surgery in patients with high-risk, muscle-invasive urothelial carcinoma, met primary endpoints of improving disease-free survival (DFS) versus placebo in both all randomized patients and in patients whose tumor cells express PD-L1 ≥1% (programmed death-ligand 1).
President Donald Trump signaled the White House may attempt to override a more stringent guidance for Emergency Use Authorization of a vaccine for the novel coronavirus under consideration by the U.S.Food and Drug Administration (FDA).
A federal appeals court overturned a judge’s approval of a novel plan by lawyers representing cities and counties suing drug companies over the U.S. opioid crisis that would bring every community nationally into their settlement talks.
With $29 million in the company’s pocket, biotech Libra Therapeutics launched to take on neurodegenerative disease, with three pre-clinical programs ready to roll.
Becton Dickinson and Co. reached a $60 million settlement with the attorneys general of 48 U.S. states and Washington D.C., resolving allegations the company concealed the risks of now-discontinued pelvic mesh devices.
After attending several virtual scientific conferences since the start of the COVID-19 lockdown, TBWA\WorldHealth explores which practices should stay, which ones will need to come back, and how pharmaceutical brands can stand out in this medium.
W2O, a leading independent provider of analytics-driven technology-enabled marketing and communications solutions to the healthcare sector, announced the acquisition of Elysia Group, a health economic and outcomes research (HEOR) consulting firm operating in the United States and Asia Pacific.
Denials management is an ongoing issue that is always surrounded by a buzz of industry noise. This webinar aims to cut through the noise with practical tips for defining, classifying, and tracking denials from someone who has spent years doing that work herself.